Swedish Institute competitors

Tom is a student Northwestern University Feinberg School of Medicine starting in 2015 and is based in Chicago, Illinois. He is a President and CEO at Ann & Robert H Lurie Children's Hospital of Chicago. Tom has worked as Associate Dean for Clinical and Translational Research at University of Michigan, Chairman and Chief Research Officer at Ann & Robert H Lurie Children's Hospital of Chicago, and Lurie Children's Chicago Marathon Team at Ann & Robert H Lurie Children's Hospital of Chicago. He attended Carleton College between 1981 and 1985, University of Chicago between 1985 and 1989, and University of Chicago Booth School of Business between 2019 and 2019.

An advocate for improving quality and access in healthcare, Tom Priselac has developed strategic and operational innovations to foster high-quality, safe and efficient care for patients. Under his leadership, Cedars-Sinai has earned an international reputation for quality care, community service, research and education while evolving from a community hospital to a major health system that continues to expand to better serve patients. Tom’s perspectives on healthcare delivery and policy are sought by a wide variety of groups. He is a past chair of the American Hospital Association Board of Trustees and a past chair of the Association of American Medical Colleges. He was chair of the American Hospital Association in 2009, during the development of Affordable Care Act. He also formerly chaired the California Hospital Association and the Hospital Association of Southern California.Among his leadership roles in organizations working to strengthen the communities of Los Angeles, Tom is a member of the Board of Councilors of the Charles R. Drew University of Medicine and Science, Civic Alliance, the Los Angeles Coalition for the Economy and Jobs, the Los Angeles County Economic Development Corporation and the Los Angeles Area Chamber of Commerce. He has received numerous awards for leadership in healthcare and his commitment to improving the health of the underserved, including the American Hospital Association’s Distinguished Service Award, the AAMC Distinguished Service Award, the Special Needs Network’s Distinguished Community Champion Corporate Leadership Award and the Charles R. Drew University Board of Trustees Medal of Honor.Tom writes and speaks on a variety of policy issues related to the delivery and financing of healthcare, healthcare quality and safety, and the adoption and implementation of information technology. He is an adjunct professor at the UCLA Fielding School of Public Health, where he teaches principles of organizational leadership.

Kenneth L. Davis is president and chief executive officer of the Mount Sinai Health System in New York City, an American author and medical researcher who developed the Alzheimer's Disease Assessment Scale, the most widely used tool to test the efficacy of treatments for Alzheimer's Disease designed specifically to evaluate the severity of cognitive and noncognitive behavioral dysfunctions characteristic to persons with Alzheimer's disease.

Jeff Sperring is a Chief Executive Officer at Seattle Children's Healthcare System and Chief Executive Officer at SEATTLE CHILDREN'S HOSPITAL. He has worked as Chief Medical Officer at Riley Hospital and President/CEO at Riley Hospital. Jeff attended Emory University.

Forty years of progressively responsible experience in the health care industry, fifteen with multi-billion dollar academic health care systems that represent some of the most complex, progressive and successful healthcare organizations in the United States, including the Johns Hopkins, MedStar and University of Maryland Health Systems in Baltimore, MD and the Jefferson Health System in Philadelphia, PA.

Dr. Gottfried Kellermann H. is a President and Chief Executive Officer at NEUROSCIENCE INC and is based in United States.